POSITION:HOME > Chinese Medicines> Toripalimab> Toripalimab Medication Guide
Toripalimab
Toripalimab Toripalimab

Toripalimab(特瑞普利单抗注射液)

As a domestic PD-1 inhibitor, Toripalimab Injection is advantageous for its broad-spectrum anti-tumor effect, definite efficacy of monotherapy or combination chemotherapy against various advanced solid tumors.

  • 240mg(6ml)/vial
  • {pboot:if('80mg(2ml)/vial' != '')}
  • 80mg(2ml)/vial
  • {else}{/pboot:if}

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.
Authentic
Guarantee
Fast Delivery
Privacy

Toripalimab Medication Guide

Recommended

  • Drug-Drug Interactions of Toripalimab

    Toripalimab is a PD-1 inhibitor classified as an immune checkpoint inhibitor, mainly used for the treatment of various malignant tumors (e.g., melanom···【Read More】

    Update: 11 Feb,2026Source: Haiou HealthViews: 75

  • Precautions for Toripalimab

    Toripalimab (anti-PD-1 monoclonal antibody) is mainly indicated for the treatment of advanced solid tumors (such as melanoma, nasopharyngeal carcinoma···【Read More】

    Update: 11 Feb,2026Source: Haiou HealthViews: 75

  • Side Effects of Toripalimab

    Toripalimab is a PD-1 inhibitor, a type of tumor immunotherapeutic drug, mainly used for the treatment of malignant tumors such as melanoma and nasoph···【Read More】

    Update: 11 Feb,2026Source: Haiou HealthViews: 72

  • How many vials of Toripalimab are used per dose

    The recommended dose of toripalimab is usually 3 mg per kg of body weight, administered once every 2 weeks. The exact number of vials per dose is calc···【Read More】

    Update: 11 Feb,2026Source: Haiou HealthViews: 76

  • Toripalimab Instruction Manual

    Toripalimab is an anticancer drug classified as a PD-1 inhibitor. Its main ingredient is a monoclonal antibody targeting the PD-1 receptor on the surf···【Read More】

    Update: 11 Feb,2026Source: Haiou HealthViews: 76

  • Special Populations for Toripalimab Use

    Toripalimab (a PD-1 inhibitor) should be used in special populations strictly following the principle of individualization. Key populations include ch···【Read More】

    Update: 11 Feb,2026Source: Haiou HealthViews: 74

Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH

whatsAppIcon

Order on WhatsApp